Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00156273 · ClinicalTrials.gov registry record
Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer
A clinical trial, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- 69
- Enrollment target
NCT00156273: Completed study, sponsored by University of Michigan Rogel Cancer Center.
NCT00156273 is a clinical trial that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 69 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00156273 has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- 69 participants
- Enrollment target
Study Summary
We are trying to develop better ways to detect when cancer therapies are working.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2005-04 |
| Est. Completion | 2008-10 |
What the finished NCT00156273 record still lists
NCT00156273 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 69 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00156273 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00156273 about?
NCT00156273 is a clinical study titled "Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer". We are trying to develop better ways to detect when cancer therapies are working.
What is the current status of trial NCT00156273?
This trial is currently completed. The enrollment target is 69 participants. The study started on 2005-04. Estimated completion is 2008-10.
Who is sponsoring clinical trial NCT00156273?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04020575 · 69 participants · Phase 1
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
- NCT04163614 · 69 participants · NA
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
- NCT04164641 · 69 participants · NA
Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration
- NCT04493372 · 69 participants · NA
Deciphering Preserved Autonomic Function After Spinal Cord Injury
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia